Patents by Inventor Carsten Andersen

Carsten Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8986668
    Abstract: A method of manufacturing a nicotine delivery product comprising nicotine and a cation exchange resin. More precisely, to a method for preparing a nicotine delivery product said method comprising (a) mixing nicotine, a cation exchange resin, an organic polyol and water to form a mixture wherein the total amount of water is from 26 to 45% by weight of the total mixture, and (b) removing water from the mixture to produce said nicotine delivery product.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: March 24, 2015
    Assignee: Fertin Pharma A/S
    Inventor: Carsten Andersen
  • Publication number: 20150079628
    Abstract: The present invention relates to a process for enzymatic hydrolysis of granular starch into a soluble starch hydrolysate at a temperature below the initial gelatinization temperature of said granular starch.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Anders Vikso-Nielsen, Carsten Andersen, Sven Pedersen, Carsten Hjort
  • Publication number: 20150044732
    Abstract: The present invention relates to variants of a parent alpha-amylase, the variant having improved stability or activity at low calcium conditions or at low pH.
    Type: Application
    Filed: October 28, 2014
    Publication date: February 12, 2015
    Inventor: Carsten Andersen
  • Publication number: 20150034111
    Abstract: A chewing gum formulation including tobacco particles and a gum base, where the gum base includes one or more hydrophobic gum base polymers, and where the tobacco particles are made from tobacco leaves. The amount of tobacco particles is between 0.5 and 30% by weight of the chewing gum formulation, and nicotine is released from the tobacco particles when chewing the chewing gum formulation.
    Type: Application
    Filed: October 20, 2014
    Publication date: February 5, 2015
    Inventor: Carsten Andersen
  • Publication number: 20150024084
    Abstract: The present invention relates to a phytase which has at least 74% identity to a phytase derived from Citrobacter braakii and comprises at least one alteration as compared to this phytase. These phytase variants have amended, preferably improved, properties, such as thermostability, temperature profile, pH profile, specific activity, performance in animal feed, reduced protease sensitiliby, and/or an amended glycosylation pattern. The invention also relates to DNA encoding these phytases, methods of their production, as well as the use thereof, e.g., in animal feed and animal feed additives.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 22, 2015
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Kobberoee Skov, Mikael Blom Soerensen
  • Patent number: 8913517
    Abstract: Methods for measuring the sensitivity of a data packet signal receiver are provided by varying the power level or modulation or both of a received data packet signal in a predetermined controlled sequence of data packet signals.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: December 16, 2014
    Assignee: LitePoint Corporation
    Inventors: Christian Volf Olgaard, Carsten Andersen
  • Publication number: 20140356924
    Abstract: The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered properties relative to the parent alpha-amylase.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 4, 2014
    Inventors: Allan Svendsen, Carsten Andersen, Thomas Thisted, Claus von der Osten
  • Patent number: 8900848
    Abstract: The present invention relates to variants of a parent alpha-amylase, the variant having improved stability or activity at low calcium conditions or at low pH.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: December 2, 2014
    Assignee: Novozymes A/S
    Inventor: Carsten Andersen
  • Patent number: 8883970
    Abstract: The present invention relates to variants (mutants) of polypeptides, in particular Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits an alteration in at least one of the following properties relative to said parent alpha-amylase: substrate specificity, substrate binding, substrate cleavage pattern, thermal stability, pH/activity profile, pH/stability profile, stability towards oxidation, Ca2+ dependency, specific activity, and solubility, in particular under production conditions.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: November 11, 2014
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Torben Vedel Borchert, Bjarne Rønfeldt Nielsen
  • Patent number: 8877471
    Abstract: The present invention relates to a phytase which has at least 74% identity to a phytase derived from Citrobacter braakii and comprises at least one alteration as compared to this phytase. These phytase variants have amended, preferably improved, properties, such as thermostability, temperature profile, pH profile, specific activity, performance in animal feed, reduced protease sensitiliby, and/or an amended glycosylation pattern. The invention also relates to DNA encoding these phytases, methods of their production, as well as the use thereof, e.g. in animal feed and animal feed additives.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: November 4, 2014
    Assignee: Novozymes A/S
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Kobberoee Skov, Mikael Blom Soerensen
  • Publication number: 20140322795
    Abstract: The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase.
    Type: Application
    Filed: July 14, 2014
    Publication date: October 30, 2014
    Inventors: Carsten Andersen, Christel Thea Jorgensen, Henrik Bisgaard-Frantzen, Allan Svendsen, Soren Kjaerulff
  • Patent number: 8863756
    Abstract: A chewing gum formulation including tobacco particles and a gum base, where the gum base includes one or more hydrophobic gum base polymers, and where the tobacco particles are made from tobacco leaves. The amount of tobacco particles is between 0.5 and 30% by weight of the chewing gum formulation, and nicotine is released from the tobacco particles when chewing the chewing gum formulation.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: October 21, 2014
    Assignee: Okono A/S
    Inventor: Carsten Andersen
  • Patent number: 8859255
    Abstract: The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: October 14, 2014
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Christel Thea Jorgensen, Henrik Bisgaard-Frantzen, Allan Svendsen, Soren Kjaerulff
  • Patent number: 8858919
    Abstract: The invention relates to a method of relieving nicotine craving comprising the steps of providing at least one chewing gum comprising tobacco alkaloid to a user, providing relief of nicotine craving to said user by transferring of tobacco alkaloid from the chewing gum to the human body of said user by chewing of said chewing gum, said chewing of said chewing gum comprising a chewing process involving a transfer of tobacco alkaloid from said chewing gum above a threshold transfer rate in the period of about ½ minute to about 2½ minutes from initiation of said chewing process.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: October 14, 2014
    Assignee: Fertin Pharma A/S
    Inventor: Carsten Andersen
  • Publication number: 20140255550
    Abstract: The invention relates to a novel 3D structure encoding a Nocardiopsis protease, as well as to variants of parent protease homologous to Nocardiopsis proteases, preferably of improved thermostability and/or with an amended temperature activity profile. The invention also relates to DNA sequences encoding such variants, their production in a recombinant host cell, as well as methods of using the variants, in particular within the field of animal feed and detergents. The invention furthermore relates to methods of generating and preparing protease variants of amended properties.
    Type: Application
    Filed: May 23, 2014
    Publication date: September 11, 2014
    Applicant: Novozymes A/S
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Lehmann Hyllling Christensen, Soren Flensted Lassen, Peter Rahbek Ostergaard
  • Patent number: 8828361
    Abstract: The invention relates to a tobacco alkaloid releasing chewing gum comprising tobacco alkaloid, gum base, and chewing gum ingredients, said gum base comprising elastomer and resin-compounds constituting an amount in the range of about 2 to 20% by weight of said chewing gum.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: September 9, 2014
    Assignee: Fertin Pharma A/S
    Inventor: Carsten Andersen
  • Patent number: 8828460
    Abstract: The inventors have modified the amino acid sequence of a maltogenic alpha-amylase to obtain variants with improved properties, based on the three-dimensional structure of the maltogenic alpha-amylase Novamyl. The variants have altered physicochemical properties., e.g. an altered pH optimum, improved thermostability, increased specific activity, an altered cleavage pattern or an increased ability to reduce retrogradation of starch or staling of bread.
    Type: Grant
    Filed: August 27, 2013
    Date of Patent: September 9, 2014
    Assignee: Novozymes A/S
    Inventors: Joel Cherry, Allan Svendsen, Carsten Andersen, Lars Beier, Torben Peter Frandsen
  • Publication number: 20140248685
    Abstract: The invention relates to a variant of a parent Termamyl-like ?-amylase, which exhibits an alteration in at least one of the following properties relative to said parent ?-amylase: i) improved pH stability at a pH from 8 to 10.5; and/or ii) improved Ca2+ stability at pH 8 to 10.5, and/or iii) increased specific activity at temperatures from 10 to 60° C.
    Type: Application
    Filed: January 24, 2014
    Publication date: September 4, 2014
    Applicant: NOVOZYMES A/S
    Inventors: Torben Vedel Borchert, Allan Svendsen, Carsten Andersen, Bjarne Nielsen, Torben Lauesgaard Nissen, Soren Kjaerulff
  • Publication number: 20140234906
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 17, 2012
    Publication date: August 21, 2014
    Inventors: Carsten Andersen, Signe Eskildsen Larsen, Esben Peter Friis, Peter Kamp Hansen, Henrik Friis Madsen, Anders Viksoe Nielsen, Pernille Ollendorf Micheelsen
  • Publication number: 20140230833
    Abstract: A nicotine delivery product comprising the reaction product of a nicotine/cation exchange resin complex and an organic polyol; and a method for preparing it comprising (a) mixing an aqueous suspension of a nicotine/cation exchange resin complex with an organic polyol or an aqueous solution thereof, and (b) removing water from the mixture to produce said nicotine delivery product. The nicotine delivery product has a nicotine release rate of at least 80% over a 10 minute period. It is particularly suited for use in smoking substitution devices delivering nicotine such as chewing gum, patches, lozenges, melting tablets and tablets for chewing.
    Type: Application
    Filed: April 24, 2014
    Publication date: August 21, 2014
    Applicant: Fertin Pharma A/S
    Inventor: Carsten ANDERSEN